"A blood protein produced in response to and counteracting a specific antigen. Antibodies combine chemically with substances which the body recognizes as alien, such as bacteria, viruses and foreign substances in the blood."Antibody timi cu "thi chungah a ummi protein dat a si i, titsa a hrawk khotu rungrul/hnawmtam (antigen) timi pawl taksa chung i an luh tik ah, a rak theih i a rak dohtu a si. Cucu dat (chemical) le taksa thilri hna he bawm in sermi a si. Cu "antibody" timi nih cun, taksa chungah a leng in a rak lutmi zawtnak rungrul (bacteria), tlangrairungrul (viruses) le a lengin thisen ah a rak lutmi lenglei thil (alien) pawl kha a rak thei khotu le doh kho tu a si.
Covid-19 dohnak ding caah, cu antibody timi Eli Lilly and Company nih minung cungah a hmasatbik hniksaknak kan thawk cang tiah tu chun Nikhatni ah an ti.
A pakhatnak bik hniksak an tuahmi cu Coviwill test taih an ti i, cu sii cu hman tik ah, Covid-19 mizaw thlawpnak caah a tha i, minung caah tihnung a si maw silo timi kha hniksak hmasat ding a si. A phichuak cu June thla dih lei ah a fiang te lai tiah an ti. A pakhatnak bik hniksakmi Covid-19 mizaw hna cu, New York University's Grossman School of Medicine, New York le Cedars-Sinai timi sizung Los Angelis ummi le Emory University, Atlanta ummi an si tiah CNN nih report an tuah.
Hi antibody sii hi Covid-19 mizaw dohnak caah a tha ko ti a si ahcun, khuasik tlak hlan ah mipi sinah biatak tein hman khawh a si cang lai tiah Indianapolis-khua ummi company Eli Lilly's company nih an chim.
"Nihin ni tiang ahcun scientist pawl nih hin, sii thar an siam kho theng rih. A um ciami sii tu kha tinhmi thar in an serchuah i, a tu zawtnak thar Covid-19 thlawpnak ah a tha maw tha lo tiah an hman hna bia tu a si. Cucaah hi zawtnak thar a chuah tikah, cu zawtnak dohnak ca hrimhrim ah, a tharmi sii kan ser a herh" tiah Dr. Dan Skovronsky nih a ti. A mah cu Eli Lilly's company ah senior vice-President le science lei i chief officer a si. "A tu cu Covid-19 mizaw cungah kan hniksak cang lai" tiah an ti. Hi sii hi a thar mi a si caah, a that ahcun Covid-19 teinak ding hi, ruahchannak a um ngai.
Hi antibody sii hi Canada ram ah a ummi, AbCellera timi biotechnology company le Eli Lilly's company bawm in an serchuahmi a si. Covid-19 dohnak le thlawpnak caah tinhmi ngei tein an ser tharmi sii a si.
US cozah nih an fehter cangmi Remdisivir zong hi, Covid-19 caah an sermi a rak si lo. Ebola zawtnak dohnak caah an rak sermi a si. Asinain Ebola zawtnak dohnak caah an hman tikah a tha tuk lo ti a si. Covid-19 thlawpnak ca an hman tikah, mizaw hi an dam a rang deuh ti a si caah, "Emergency in an hmanter mi hna a si. Study an tuah lio a si rih.
Minung pakhat Covid-19 in a zawt i a dam tik ah, cu mizaw taksa le thisen nih "antibodies" timi protein hi million tam tuk aa serchuah . Cu antibodies timi rungrul dohtu thisen nih cun zawtnak rungrul kha a doh i, mizaw kha a damter.
AbCellera Compaby nih USA i Covid-19 in a zaw hmasat bikmi a dammi taksa le thisen in cells millions tampi an khawmhsuat i, cu chung in rungrul dohtu "antibodies" a zaza in an hmuh.
Hi runrul doh khotu "antibodies" an rak hmuh hlan ah, Covid-19 in a zaw i a dammi thisen hi,
Covid-19 in mizaw kha an thlawp tik hna ah, an dam a rang deuh tiah ca an rak tial bal. Cucu a tu i, Eli Lilly's company nih an hmuh tharmi "antibodies" timi rungrul dohtu thisen ruangah a si kho mi a si.
Lilly scientist pawl nih hin, "monoclonal" timi antibody mizaw thlawpnak zong hi an ser. Hi bantuk thlawpnak hi zawtnak phundang tampi zong ah an hman hna. Monocolnal antibody zawt thlawpnak cu HIV, asthma, lupus, Ebola le cancer cheu khat thlawpnak ah an hman hna.
Hi Eli Lilly's company nih an chuahtharmi "antibodies" sii hi Covid-19 thlawpnak ah a that ahcun Covid-19 hi hmailei ahcun tei khawh a si te ko lai tiah ruahchannak nganpi a um. Hihi a that ahcun a sertu company zong min a tha lai. Rumnak tiang zong a si kho lai. Company headquarter umnak Indianapolis zong a min a tha ding a si. Cun hi sii hi a that ahcun stock market zong a kai than lai i, US sipuazi zong hi a kaiter khawh te ding a si.
Scientist nih Covid-19 khamnak sii le thlawpnak sii tha mi an hmuh hlan ahcun USA hi zei thil hmanh punghman in a kal kho ti lai lo.
 |
| Eli Lilly Biotechnology Corporate Headquarter, Indianapolis |
Eli Lilly and Company hi, sii chuahtu "American pharmaceutical company" pakhat a si I, Indianapolis ah a ummi a si. Ram 18 ah zung an ngei. An chuahmi sii le thilri hi ram 125 ah an zuar. Hi company hi 1876 ah Col. Eli Lilly timi pa nih a dirhmi a si. A mah cu Civil War ralkap pension a si. Sii le thiammi chemist timi a si. Sii thatha tampi a sertu an si i, polio zawtnak khamnak sii zong tam taktak in a chuah kho hmasattu cu an mah hi an si. Riantuantu 33,815 (2019) ah an um. An rumnak hi 43.9 billion a si. Kum khat chung ngunkhuai an chuahpimi dihlak hi 24.55 billion a si. An miakmi hi 3.23 billilon a si. A rum taktakmi le a lian taktakmi sii company a si.
Chinchiah
Sii le science kong hi, Lai biafang nih a leh khawhlomi le a tlinhlomi a tamtuak caah, a tanglei website ah tling deuh in rel khawh a si. Mirang ca hi Laica in leh le tial a har caah, a naihnak bik in ka zoh chih i ka tialmi a si.
Hi ca hi CNN catialtu, Jen Christensen tialmi First human trial of potential antibody treatment for Covid-19 begins timi ca zoh chih in tial a si.
https://www.cnn.com/2020/06/01/health/eli-lilly-antibody-therapy-human-trial-covid-19/index.html
No comments:
Post a Comment